Your browser doesn't support javascript.
loading
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Borenäs, Marcus; Umapathy, Ganesh; Lai, Wei-Yun; Lind, Dan E; Witek, Barbara; Guan, Jikui; Mendoza-Garcia, Patricia; Masudi, Tafheem; Claeys, Arne; Chuang, Tzu-Po; El Wakil, Abeer; Arefin, Badrul; Fransson, Susanne; Koster, Jan; Johansson, Mathias; Gaarder, Jennie; Van den Eynden, Jimmy; Hallberg, Bengt; Palmer, Ruth H.
  • Borenäs M; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Umapathy G; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Lai WY; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Lind DE; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Witek B; Department of Molecular Biology, Umeå University, Umeå, Sweden.
  • Guan J; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Mendoza-Garcia P; Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
  • Masudi T; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Claeys A; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Chuang TP; Department of Human Structure and Repair, Anatomy and Embryology Unit, Ghent University, Ghent, Belgium.
  • El Wakil A; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Arefin B; Department of Molecular Biology, Umeå University, Umeå, Sweden.
  • Fransson S; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Koster J; Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Johansson M; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Gaarder J; Clinical Genomics, Science for life laboratory, University of Gothenburg, Gothenburg, Sweden.
  • Van den Eynden J; Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Hallberg B; Department of Human Structure and Repair, Anatomy and Embryology Unit, Ghent University, Ghent, Belgium.
  • Palmer RH; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
EMBO J ; 40(3): e105784, 2021 02 01.
Article en En | MEDLINE | ID: mdl-33411331
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación hacia Arriba / Citocinas / Inhibidores de Proteínas Quinasas / Proteína Proto-Oncogénica N-Myc / Neuroblastoma Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación hacia Arriba / Citocinas / Inhibidores de Proteínas Quinasas / Proteína Proto-Oncogénica N-Myc / Neuroblastoma Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article